Eye care practitioners are well aware that medications for patients with ocular surface disease need to be proven safe through clinical trials. They probably also assume, like their patients, that basic beauty and anti-aging products are tested to be safe and not toxic to the ocular surface. This is not always the case.
Premium subscriber content
Sign in if you have a Digital or Print + Digital subscription. Don’t have one yet? Digital subscribers get full access to this article from $40/year +GST.
- Premium exclusive content
- Full digital magazine archive
- Early access to new articles
